摘要
目的探讨利拉鲁肽对糖尿病前期小鼠胰岛功能及胰岛微血管内皮细胞的作用。方法将30只雄性C57BL/6J小鼠随机分为正常饮食(Con)组、高脂饮食(HF)组、高脂饮食+利拉鲁肽干预组(LH),每组各10只,比较各组FBG、FIns、胰岛内胰岛素、CD31、血管内皮生长因子A(VEGF-A)蛋白表达及一氧化氮合酶(iNOS)、白细胞介素1β(IL-1β)mRNA表达量。结果各组FBG比较,差异无统计学意义(P>0.05)。LH组胰岛内胰岛素水平高于HF组(P<0.05),CD31蛋白表达[(0.196±0.002)vs(0.245±0.004)]及VEGF-A[(0.265±0.003)vs(0.413±0.005)]、IL-1β[(1.13±0.03)vs(1.54±0.02)]及iNOS[(1.28±0.02)vs(1.65±0.03)]mRNA表达均低于HF组(P<0.05)。结论利拉鲁肽可改善糖尿病前期小鼠胰岛功能,对胰岛微血管内皮细胞起保护作用。
Objective To explore the effect of Liraglutide on islet function and islet microvascular endothelial cells in mice with pre-diabetes. Methods Thirty male C57 BL/6 Jmice were randomly divided into three groups:control group(Con,n=10),high-fat dietgroup(HF,n=10)and high-fat diet plus Liraglutide group(LH,n=10).The FBG,FIns,the expression of insulin,CD31,VEGF-A,mRNA of iNOS and IL-1βin islet were detected. Results There was no significant difference in FBG among the three groups(P〉0.05).The concentration of insulin in the islets was higher[(0.217±0.002)vs(0.195±0.002)ng/ml,P〈0.05],the levels of CD31[(0.196±0.002)vs(0.245±0.004)],VEGF-A[(0.265±0.003)vs(0.413±0.005)],IL-1β[(1.13±0.03)vs(1.54±0.02)],and iNOS[(1.28±0.02)vs(1.65±0.03)]were lower in LH group than in HF group. Conclusion Liraglutide can improve pancreatic islet function and protect islet microvascular endothelial cells in mice with pre-diabetes.
作者
陆春丽
胡东辉
褚加成
周夏利
陈巍巍
孙明谨
LU Chunli;HU Donghui;CHU Jiacheng(Department of Endocrinology, Suizhou Hospital, Hubei University of Medicine, Suizhou 441300, China)
出处
《中国糖尿病杂志》
CAS
CSCD
北大核心
2018年第5期412-416,共5页
Chinese Journal of Diabetes
基金
湖北省自然科学基金(2016CFB128)
关键词
糖尿病前期
胰升血糖素样肽1
胰岛功能
胰岛微血管内皮细胞
Pre-diabetic
Glucagon-like peptide-1 agonist
Function of islet
Islet microvascularendothelial cell